CN107469002A - 一种抗肝纤维化的蒙药复方 - Google Patents
一种抗肝纤维化的蒙药复方 Download PDFInfo
- Publication number
- CN107469002A CN107469002A CN201710777179.5A CN201710777179A CN107469002A CN 107469002 A CN107469002 A CN 107469002A CN 201710777179 A CN201710777179 A CN 201710777179A CN 107469002 A CN107469002 A CN 107469002A
- Authority
- CN
- China
- Prior art keywords
- parts
- metancenter
- myrobalan
- muscone
- santal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种抗肝纤维化的蒙药复方,由以下重量份的原料制备而成:蒙古山萝卜花30‑40份、红花10‑20份、诃子30‑40份、人工牛黄5‑10份、内蒙古紫草12‑18份、川楝子3‑9份、五灵脂10‑20份、瞿麦10‑20份、片姜黄3‑6份、肋柱花5‑15份、乌梅5‑10份、建莲子8‑12份、草乌叶4‑8份、丁香5‑10份、厚朴(姜制)3‑6份、紫檀香3‑6份、人工麝香1‑3份、稳心草2‑5份、牛膝15‑25份、文冠果3‑7份。本发明以抗氧化为主、温阳化瘀为辅,具有较好的抗氧化以及抑制TGF‑β1表达功能,从而对肝纤维化具有很好的治疗作用;所得蒙药还具有温阳利湿、化瘀散结、健脾安神、补肾解毒、活血化瘀、舒肝和胃、理气止痛等作用。
Description
技术领域
本发明涉及蒙药领域,具体涉及一种抗肝纤维化的蒙药复方。
背景技术
肝纤维化是由于各种原因引起肝细胞损伤,激活肝星状细胞,使其转变成为肌纤维母细胞,炎症因素、毒素等刺激损伤及再生的肝细胞、Kupffer细胞、窦内皮细胞、自然杀伤(NK)细胞产生免疫介质和细胞因子,并且以自分泌或旁分泌的方式作用于靶细胞受体,使肌纤维母细胞增殖,合成大量的细胞外基质(ECM),细胞外基质增生与降解失衡,纤维结缔组织在肝脏内部的出现过多沉积,肝脏的正常的组织结构出现紊乱,从而肝脏的正常的功能也出现异常,肝纤维化是各种慢性肝脏疾病的共同病理过程。肝纤维化是可逆的,这促使广大中医学工作者对肝纤维化阶段进行了各种研究和尝试,尽可能在此阶段或者肝硬化早期进行肝纤维化的逆转,防止向肝硬化晚期及肝癌的发展。磷脂酰肌醇-3激酶/蛋白激(PI3K/Akt)信号通路与肝纤维化发生、发展过程中的肝星状细胞活化及增殖、凋亡及迁移,还有细胞外基质的分泌紧密相关。PI3K/Akt信号通路参与肝纤维化的发生与发展:被激活的PI3K/Akt信号通路,可通过调节HSC增殖和迁移以及增加I型、II型胶原的表达水平来促使肝纤维化形成;相反,阻断PI3K/Akt信号通路的激活,则可诱导HSC凋亡,促进ECM的降解,进而延缓了肝纤维化发生发展的进程。肝病患者病情不断向前进展的主要因素是炎症的不断发生,并进一步使损失的肝脏在肝纤维化不断发展的基础上向着肝硬化进展,故通过PI3K/Akt信号通路来调节肝星状细胞的活化、肝脏细胞外基质的产生和降解及肝窦毛细血管化,以达到减少肝脏内炎症反应的作用,从而发挥抗肝纤维化作用,进而延缓肝病患者病情发展,在一定程度上也可控制甚至逆转肝硬化的病情发展。氧自由基损伤和肝纤维化关系密切,氧自由基损伤是肝纤维化的始动因素之一,抗氧化作用有助于改善肝纤维化。TGF-β1是最重要的致纤维化因子之一,是抗肝纤维化药物的重要靶点。
阻止肝纤维化的形成与发展对防治肝硬化具有重要意义,抗肝纤维化药物研究和开发是目前肝病治疗的难点与热点之一,部分中药或民族药物方剂按照其理论体系和经验积累,在表现为肝纤维化慢性肝病治疗中取得了较好的疗效,具有很大的优势和潜力
发明内容
为解决上述问题,本发明提供了一种抗肝纤维化的蒙药复方,具有温阳利湿、化瘀散结、护肝保肝,具有较好的抗肝维化效果。
为实现上述目的,本发明采取的技术方案为:
一种抗肝纤维化的蒙药复方,由以下重量份的原料制备而成:
蒙古山萝卜花30-40份、红花10-20份、诃子30-40份、人工牛黄5-10份、内蒙古紫草12-18份、川楝子3-9份、五灵脂10-20份、瞿麦10-20份、片姜黄3-6份、肋柱花5-15份、乌梅5-10份、建莲子8-12份、草乌叶4-8份、丁香5-10份、厚朴(姜制)3-6份、紫檀香3-6份、人工麝香1-3份、稳心草2-5份、牛膝15-25份、文冠果3-7份。
优选地,由以下重量份的原料制备而成:
蒙古山萝卜花30份、红花10份、诃子30份、人工牛黄5份、内蒙古紫草12份、川楝子3份、五灵脂10份、瞿麦10份、片姜黄3份、肋柱花5份、乌梅5份、建莲子8份、草乌叶4份、丁香5份、厚朴(姜制)3份、紫檀香3份、人工麝香1份、稳心草2份、牛膝15份、文冠果3份。
优选地,由以下重量份的原料制备而成:
蒙古山萝卜花40份、红花20份、诃子40份、人工牛黄10份、内蒙古紫草18份、川楝子9份、五灵脂20份、瞿麦20份、片姜黄6份、肋柱花15份、乌梅10份、建莲子12份、草乌叶8份、丁香10份、厚朴(姜制)6份、紫檀香6份、人工麝香3份、稳心草5份、牛膝25份、文冠果7份。
优选地,由以下重量份的原料制备而成:
蒙古山萝卜花35份、红花15份、诃子35份、人工牛黄7.5份、内蒙古紫草15份、川楝子6份、片姜黄4.5份、肋柱花10份、乌梅7.5份、建莲子10份、草乌叶6份、丁香7.5份、厚朴(姜制)4.5份、紫檀香4.5份、人工麝香2份、稳心草3.5份、牛膝20份、文冠果5份。
优选地,由以下重量份的原料制备而成:
蒙古山萝卜花32份、红花13份、诃子32份、人工牛黄6份、内蒙古紫草14份、川楝子5份、五灵脂13份、瞿麦13份、片姜黄4份、肋柱花8份、乌梅6份、建莲子8份、草乌叶4份、丁香6份、厚朴(姜制)4份、紫檀香4份、人工麝香1份、稳心草3份、牛膝18份、文冠果4份。
优选地,由以下重量份的原料制备而成:
蒙古山萝卜花37份、红花16份、诃子36份、人工牛黄8份、内蒙古紫草16份、川楝子7份、五灵脂17份、瞿麦17份、片姜黄5份、肋柱花12份、乌梅8份、建莲子11份、草乌叶7份、丁香9份、厚朴(姜制)5份、紫檀香5份、人工麝香2份、稳心草4份、牛膝22份、文冠果6份。
本发明具有以下有益效果:
以抗氧化为主、温阳化瘀为辅,具有较好的抗氧化以及抑制TGF-β1表达功能,从而对肝纤维化具有很好的治疗作用;通过PI3K/Akt信号通路来调节肝星状细胞的活化、肝脏细胞外基质的产生和降解及肝窦毛细血管化,以达到减少肝脏内炎症反应的作用,从而发挥抗肝纤维化作用,进而延缓肝病患者病情发展,在一定程度上也可控制甚至逆转肝硬化的病情发展。所得蒙药还具有温阳利湿、化瘀散结、健脾安神、补肾解毒、活血化瘀、舒肝和胃、理气止痛等作用。
具体实施方式
为了使本发明的目的及优点更加清楚明白,以下结合实施例对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。
实施例1
一种抗肝纤维化的蒙药复方,由以下重量份的原料制备而成:
蒙古山萝卜花30份、红花10份、诃子30份、人工牛黄5份、内蒙古紫草12份、川楝子3份、五灵脂10份、瞿麦10份、片姜黄3份、肋柱花5份、乌梅5份、建莲子8份、草乌叶4份、丁香5份、厚朴(姜制)3份、紫檀香3份、人工麝香1份、稳心草2份、牛膝15份、文冠果3份。
实施例2
一种抗肝纤维化的蒙药复方,由以下重量份的原料制备而成:
蒙古山萝卜花40份、红花20份、诃子40份、人工牛黄10份、内蒙古紫草18份、川楝子9份、五灵脂20份、瞿麦20份、片姜黄6份、肋柱花15份、乌梅10份、建莲子12份、草乌叶8份、丁香10份、厚朴(姜制)6份、紫檀香6份、人工麝香3份、稳心草5份、牛膝25份、文冠果7份。
实施例3
一种抗肝纤维化的蒙药复方,由以下重量份的原料制备而成:
蒙古山萝卜花35份、红花15份、诃子35份、人工牛黄7.5份、内蒙古紫草15份、川楝子6份、片姜黄4.5份、肋柱花10份、乌梅7.5份、建莲子10份、草乌叶6份、丁香7.5份、厚朴(姜制)4.5份、紫檀香4.5份、人工麝香2份、稳心草3.5份、牛膝20份、文冠果5份。
实施例4
一种抗肝纤维化的蒙药复方,由以下重量份的原料制备而成:
蒙古山萝卜花32份、红花13份、诃子32份、人工牛黄6份、内蒙古紫草14份、川楝子5份、五灵脂13份、瞿麦13份、片姜黄4份、肋柱花8份、乌梅6份、建莲子8份、草乌叶4份、丁香6份、厚朴(姜制)4份、紫檀香4份、人工麝香1份、稳心草3份、牛膝18份、文冠果4份。
实施例5
一种抗肝纤维化的蒙药复方,由以下重量份的原料制备而成:
蒙古山萝卜花37份、红花16份、诃子36份、人工牛黄8份、内蒙古紫草16份、川楝子7份、五灵脂17份、瞿麦17份、片姜黄5份、肋柱花12份、乌梅8份、建莲子11份、草乌叶7份、丁香9份、厚朴(姜制)5份、紫檀香5份、人工麝香2份、稳心草4份、牛膝22份、文冠果6份。
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以作出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
Claims (6)
1.一种抗肝纤维化的蒙药复方,其特征在于,由以下重量份的原料制备而成:
蒙古山萝卜花30-40份、红花10-20份、诃子30-40份、人工牛黄5-10份、内蒙古紫草12-18份、川楝子3-9份、五灵脂10-20份、瞿麦10-20份、片姜黄3-6份、肋柱花5-15份、乌梅5-10份、建莲子8-12份、草乌叶4-8份、丁香5-10份、厚朴(姜制)3-6份、紫檀香3-6份、人工麝香1-3份、稳心草2-5份、牛膝15-25份、文冠果3-7份。
2.如权利要求1所述的一种抗肝纤维化的蒙药复方,其特征在于,由以下重量份的原料制备而成:
蒙古山萝卜花30份、红花10份、诃子30份、人工牛黄5份、内蒙古紫草12份、川楝子3份、五灵脂10份、瞿麦10份、片姜黄3份、肋柱花5份、乌梅5份、建莲子8份、草乌叶4份、丁香5份、厚朴(姜制)3份、紫檀香3份、人工麝香1份、稳心草2份、牛膝15份、文冠果3份。
3.如权利要求1所述的一种抗肝纤维化的蒙药复方,其特征在于,由以下重量份的原料制备而成:
蒙古山萝卜花40份、红花20份、诃子40份、人工牛黄10份、内蒙古紫草18份、川楝子9份、五灵脂20份、瞿麦20份、片姜黄6份、肋柱花15份、乌梅10份、建莲子12份、草乌叶8份、丁香10份、厚朴(姜制)6份、紫檀香6份、人工麝香3份、稳心草5份、牛膝25份、文冠果7份。
4.如权利要求1所述的一种抗肝纤维化的蒙药复方,其特征在于,由以下重量份的原料制备而成:
蒙古山萝卜花35份、红花15份、诃子35份、人工牛黄7.5份、内蒙古紫草15份、川楝子6份、片姜黄4.5份、肋柱花10份、乌梅7.5份、建莲子10份、草乌叶6份、丁香7.5份、厚朴(姜制)4.5份、紫檀香4.5份、人工麝香2份、稳心草3.5份、牛膝20份、文冠果5份。
5.如权利要求1所述的一种抗肝纤维化的蒙药复方,其特征在于,由以下重量份的原料制备而成:
蒙古山萝卜花32份、红花13份、诃子32份、人工牛黄6份、内蒙古紫草14份、川楝子5份、五灵脂13份、瞿麦13份、片姜黄4份、肋柱花8份、乌梅6份、建莲子8份、草乌叶4份、丁香6份、厚朴(姜制)4份、紫檀香4份、人工麝香1份、稳心草3份、牛膝18份、文冠果4份。
6.如权利要求1所述的一种抗肝纤维化的蒙药复方,其特征在于,由以下重量份的原料制备而成:
蒙古山萝卜花37份、红花16份、诃子36份、人工牛黄8份、内蒙古紫草16份、川楝子7份、五灵脂17份、瞿麦17份、片姜黄5份、肋柱花12份、乌梅8份、建莲子11份、草乌叶7份、丁香9份、厚朴(姜制)5份、紫檀香5份、人工麝香2份、稳心草4份、牛膝22份、文冠果6份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710777179.5A CN107469002A (zh) | 2017-08-27 | 2017-08-27 | 一种抗肝纤维化的蒙药复方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710777179.5A CN107469002A (zh) | 2017-08-27 | 2017-08-27 | 一种抗肝纤维化的蒙药复方 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107469002A true CN107469002A (zh) | 2017-12-15 |
Family
ID=60604346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710777179.5A Pending CN107469002A (zh) | 2017-08-27 | 2017-08-27 | 一种抗肝纤维化的蒙药复方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107469002A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1283492A (zh) * | 2000-08-10 | 2001-02-14 | 朋毛 | 一种治疗肝病的藏药及制备方法 |
CN102078412A (zh) * | 2009-12-01 | 2011-06-01 | 巴根那 | 一种治疗肝纤维化的蒙药制剂 |
CN106039148A (zh) * | 2016-08-09 | 2016-10-26 | 王秀兰 | 一种保肝蒙药 |
CN106728688A (zh) * | 2017-01-16 | 2017-05-31 | 周晓玲 | 抗肝纤维化的中成药 |
-
2017
- 2017-08-27 CN CN201710777179.5A patent/CN107469002A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1283492A (zh) * | 2000-08-10 | 2001-02-14 | 朋毛 | 一种治疗肝病的藏药及制备方法 |
CN102078412A (zh) * | 2009-12-01 | 2011-06-01 | 巴根那 | 一种治疗肝纤维化的蒙药制剂 |
CN106039148A (zh) * | 2016-08-09 | 2016-10-26 | 王秀兰 | 一种保肝蒙药 |
CN106728688A (zh) * | 2017-01-16 | 2017-05-31 | 周晓玲 | 抗肝纤维化的中成药 |
Non-Patent Citations (2)
Title |
---|
王妍等: "肝纤维化中医药治疗进展", 《中西医结合肝病杂志》 * |
苏布德达: "蒙药红花清肝13味丸治疗肝纤维化大鼠的实验研究", 《北方药学》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1322878C (zh) | 一种治疗疼痛的中药 | |
CN102961729B (zh) | 一种治疗静脉曲张、血栓闭塞性脉管炎及静脉炎的外用中药 | |
CN101703603B (zh) | 治疗烧伤的外用软膏及其制备方法 | |
CN101152568A (zh) | 具有促进血管形成、组织再生及伤口愈合作用的多肽组合制剂 | |
US9241966B1 (en) | External-use traditional chinese medicine for ichthyosis and xerodermia, and preparation method thereof | |
CN107469002A (zh) | 一种抗肝纤维化的蒙药复方 | |
CN103919896A (zh) | 一种治疗静脉炎外敷中药制剂 | |
CN104208317B (zh) | 治疗骨质增生及风湿寒热性疾病的外用搽剂及其制备方法 | |
CN110559378B (zh) | 一种复方糖足生脉膏及其制备方法 | |
CN102631426A (zh) | 一种治疗过敏性紫癜的中药组合物 | |
CN105232942A (zh) | 一种治疗全身性肌张力障碍的中药组合物 | |
CN102552609B (zh) | 治疗水疱型脚气的中药足浴组合物 | |
CN104800427A (zh) | 一种烧烫伤康复敷剂及其制备方法 | |
CN104432595A (zh) | 仿生保健内衣 | |
CN104173486B (zh) | 一种治疗跟腱炎的中药膏 | |
CN108272920A (zh) | 一种治疗烧伤喷雾剂及其制备方法 | |
CN108273022A (zh) | 通经活气、排湿减肥、降三高的中药浴粉及制备和应用 | |
CN102727641A (zh) | 一种治疗浅表性静脉炎的外敷中药 | |
CN102188654B (zh) | 一种治疗多发性神经纤维瘤的中药组合物 | |
CN104162078A (zh) | 一种治疗青春痘的中药 | |
CN101721503A (zh) | 一种治疗男女不孕不育症的中药制剂 | |
CN103494903B (zh) | 一种治疗肌肤烫伤烧伤的外用中草药剂及制备方法 | |
CN105663868A (zh) | 一种治疗再生障碍性贫血的中药组合物 | |
CN104758647A (zh) | 一种治疗风湿性关节炎的中药酒及其制备方法 | |
CN101537124B (zh) | 一种治疗烧伤的药膏 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171215 |
|
RJ01 | Rejection of invention patent application after publication |